ANTISENSE THERAPEUTICS LIMITED
ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO
Thu, 29 Jun 2006 02:00PM
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Mr Mark Diamond
Thu, 29 Jun 2006
02:00PM Australia/NSW
Boardroom Radio Tools
Select a tab above to display more information
 NOVOGEN LIMITED
(NRT)
|
NRT - Healthy Investment eConference - Mr Christopher Naughton, Managing Director Wed, 3 Dec 2008 11:15AM |
    |
 MESOBLAST LIMITED
(MSB)
|
MSB - Healthy Investment eConference - Professor Silviu Itescu, Executive Director Wed, 3 Dec 2008 11:00AM |
|
 BIOTECH CAPITAL LIMITED
(BTC)
|
BTC - Healthy Investment eConference - Harry Karelis, Executive Director Wed, 3 Dec 2008 02:45PM |
|
ANTISENSE THERAPEUTICS LIMITED (ANP)
ASX code: ANP
Website: http://www.antisense.com.au/
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
The development of novel antisense pharmaceuticals for commercially important human conditions.
Address:
10 Wallace Avenue, Level 1
TOORAK
VIC
Phone: (03) 9827 8999
Fax: (03) 9827 1166
Executives & Directors
Mr Robert Moses , Chairman
Mr Mark Diamond , CEO
Mr Chris Belyea , Non Exec. Director
Prof. Graham Mitchell , Non Exec. Director
Prof. George Werther , Non Exec. Director
Mr Phillip Hains , CFO
Ms Kate Plumridge (Joint Co. Secretary) , Company Secretary
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Please refer to the relevant stock exchange if any of the above information is incorrect
ANTISENSE THERAPEUTICS LIMITED (ANP) Events
| Company (Stock Code) | Date/Time | Event | Timezone: Australia/NSW |
|---|---|---|---|
|
Thu, 29 Jun 2006 02:00PM |
ANP - Commencement of Phase IIa Multiple Sclerosis Trial - Mr Mark Diamond, CEO |
   |
| Fri, 31 Oct 2008 10:00AM |
Annual General Meeting Minter Ellison Lawyers, Rialto Towers, 525 Collins St, Melbourne, VIC
|
||
| Wed, 13 Aug 2008 | Full Year Results | ||
| Mon, 4 Feb 2008 | Interim Results | ||
| Wed, 21 Nov 2007 10:00AM |
Annual General Meeting Computershare Conference Centre, 452 Johnston Street Abbotsford Victoria
|
||
| Wed, 28 Mar 2007 | EGM | ||
| Tue, 30 Jan 2007 | Interim Results | ||
| Tue, 10 Oct 2006 11:00AM |
Annual General Meeting Computershare Conference Centre, Yarra Falls, 452 Johnston Street Abbotsford VIC 3067
|
||
| Mon, 7 Aug 2006 | Full Year Results | ||
| Fri, 17 Feb 2006 | Interim Results | ||
| Thu, 20 Oct 2005 | Annual General Meeting | ||
ANTISENSE THERAPEUTICS LIMITED (ANP)
| ATL1101 intellectual property portfolio strengthened | Wed, 19 Nov 2008 |
| Change of Director`s Interest Notice - RM | Thu, 6 Nov 2008 |
| Change of Director`s Interest Notice - RM | Wed, 5 Nov 2008 |
| Annual General Meeting Presentation | Fri, 31 Oct 2008 |
| Results of 2008 Annual General Meeting | Fri, 31 Oct 2008 |
| ANP to Present at Rodman and Renshaw Healthcare Conference | Tue, 28 Oct 2008 |
| Appendix 3B | Mon, 27 Oct 2008 |
| Change of Director`s Interest Notice - GW, RM, MD, CB, GM | Mon, 27 Oct 2008 |
| ATL1101 Preclinical Data in Prostate Cancer-US Presentation | Fri, 17 Oct 2008 |
| ATL1101 suppresses tumours in prostate cancer animal study | Wed, 15 Oct 2008 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.
